Traws Pharma Inc (TRAW)
NASDAQ: TRAW · IEX Real-Time Price · USD
0.641
-0.024 (-3.62%)
At close: Apr 24, 2024, 3:58 PM
0.651
+0.009 (1.43%)
After-hours: Apr 24, 2024, 5:51 PM EDT

Traws Pharma Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Revenue
0.230.230.230.232.181.230.795.5511.460.8
Upgrade
Revenue Growth (YoY)
0%0%-2.16%-89.42%77.77%56.04%-85.81%-51.59%1332.00%-83.17%
Upgrade
Gross Profit
0.230.230.230.232.181.230.795.5511.460.8
Upgrade
Selling, General & Admin
9.098.459.438.338.357.597.419.189.5315.12
Upgrade
Research & Development
11.4311.417.316.915.5416.9219.1220.0725.949.43
Upgrade
Operating Expenses
20.5219.8516.7225.2223.8824.5126.5229.2535.4364.54
Upgrade
Operating Income
-20.3-19.63-16.5-24.99-21.7-23.28-25.74-23.7-23.97-63.74
Upgrade
Other Expense / Income
-1.35-0.66-0.330.16-0.21-2.59-1.66-4.05-0.01-0.08
Upgrade
Pretax Income
-18.95-18.96-16.16-25.15-21.49-20.7-24.08-19.65-23.96-63.66
Upgrade
Income Tax
00000.01-0.120.010.010.020.02
Upgrade
Net Income
-18.95-18.96-16.16-25.16-21.5-20.57-24.09-19.67-23.98-63.68
Upgrade
Shares Outstanding (Basic)
21211712100000
Upgrade
Shares Outstanding (Diluted)
21211712100000
Upgrade
Shares Change
0.39%24.22%45.08%1109.89%248.79%587.33%103.32%94.66%5.02%104.37%
Upgrade
EPS (Basic)
-0.90-0.91-0.96-2.17-22.35-74.85-602.25-999.00-2371.50-6614.99
Upgrade
EPS (Diluted)
-0.90-0.91-0.96-2.17-22.35-74.85-602.25-999.00-2371.50-6614.99
Upgrade
Free Cash Flow
-17.95-16.29-19.49-23.09-20.89-22.7-23.82-15.81-31.24-57.88
Upgrade
Free Cash Flow Per Share
-0.85-0.78-1.16-1.99-21.78-82.55-595.48-803.75-3090.86-6013.84
Upgrade
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
-8981.42%-8684.51%-7299.12%-10819.48%-994.00%-1895.93%-3270.27%-427.39%-209.25%-7968.00%
Upgrade
Profit Margin
-8384.07%-8391.15%-7151.77%-10890.48%-985.02%-1675.33%-3061.25%-354.62%-209.31%-7960.25%
Upgrade
Free Cash Flow Margin
-7940.71%-7209.73%-8622.57%-9995.67%-956.76%-1848.21%-3026.68%-285.12%-272.68%-7234.50%
Upgrade
EBITDA
-18.93-18.95-16.15-25.14-21.48-20.64-23.99-19.56-23.81-63.23
Upgrade
EBITDA Margin
-8376.99%-8384.96%-7145.58%-10883.12%-983.92%-1680.94%-3048.41%-352.63%-207.86%-7903.63%
Upgrade
Depreciation & Amortization
0.020.010.010.010.010.060.090.10.150.43
Upgrade
EBIT
-18.95-18.96-16.16-25.15-21.49-20.7-24.08-19.65-23.96-63.66
Upgrade
EBIT Margin
-8384.07%-8391.15%-7151.77%-10888.74%-984.56%-1685.42%-3059.59%-354.36%-209.17%-7957.88%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).